NMR spectroscopic detection of interactions between a HIV protein sequence and a highly anti-HIV active curdlan sulfate

被引:24
作者
Jeon, KJ
Katsuraya, K
Inazu, T
Kaneko, Y
Mimura, T
Uryu, T [1 ]
机构
[1] Teikyo Univ Sci & Technol, Yamanashi 4090193, Japan
[2] Univ Tokyo, Inst Ind Sci, Minato Ku, Tokyo 106, Japan
[3] Noguchi Inst, Itabashi Ku, Tokyo, Japan
[4] Ajinomoto Co Inc, Chuo Ku, Tokyo, Japan
关键词
D O I
10.1021/ja001577j
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
A new method is found for the detection of interactions between a highly anti-HIV (human immunodeficiency virus) active curdlan sulfate (CS) and a HIV peptide with the aid of NMR spectroscopy. To elucidate the action mechanism of the anti-HIV activity in curdlan sulfate, a partial peptide sequence in an envelope glycoprotein gp120 was synthesized. The sequence consists of a dimer (D518) of the sequence from no. 506 to 518, which is one of putative reaction sites for the sulfated polysaccharide. This was used to examine its interactions with CS. When CS and D518 were mixed in appropriate molar ratios, gel-like materials were formed. H-1 NMR spectra of the gel-like material revealed the formation of interpolymeric ionic interactions between a negatively charged CS and a positively charged D518. At the molar ratio [CS]/[D518] of 0.27, 100% gel formation was observed. Effects of molar ratio, pH, and temperature on the gel formation, that is, the degree of interaction, were also studied. In addition, although for a V3 region peptide sequence, i.e., nos. 309 to 331, the same method was applied, the mixing of CS with the V3 peptide did not provide gels, but yielded precipitates which afforded no structural information by solution NMR spectroscopy.
引用
收藏
页码:12536 / 12541
页数:6
相关论文
共 31 条
  • [1] CURDLAN SULFATE AND HIV-1 .1. INVITRO INHIBITORY EFFECTS OF CURDLAN SULFATE ON HIV-1 INFECTION
    AOKI, T
    KANEKO, Y
    STEFANSKI, MS
    NGUYEN, T
    TING, RCY
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1991, 7 (04) : 409 - 415
  • [2] SULFATED POLYSACCHARIDES ARE POTENT AND SELECTIVE INHIBITORS OF VARIOUS ENVELOPED VIRUSES, INCLUDING HERPES-SIMPLEX VIRUS, CYTOMEGALO-VIRUS, VESICULAR STOMATITIS-VIRUS, AND HUMAN IMMUNODEFICIENCY VIRUS
    BABA, M
    SNOECK, R
    PAUWELS, R
    DECLERCQ, E
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (11) : 1742 - 1745
  • [3] Design, synthesis, and conformational analysis of a novel series of HIV protease inhibitors
    Baker, CT
    Salituro, FG
    Court, JJ
    Deininger, DD
    Kim, EE
    Li, BQ
    Novak, PM
    Rao, BG
    Pazhanisamy, S
    Schairer, WC
    Tung, RD
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (24) : 3631 - 3636
  • [4] Braun S, 2000, 150 and More Basic NMR Experiments: A Practical Course Second Expanded Edition
  • [5] DEXTRAN SULFATE BLOCKS ANTIBODY-BINDING TO THE PRINCIPAL NEUTRALIZING DOMAIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 WITHOUT INTERFERING WITH GP120-CD4 INTERACTIONS
    CALLAHAN, LN
    PHELAN, M
    MALLINSON, M
    NORCROSS, MA
    [J]. JOURNAL OF VIROLOGY, 1991, 65 (03) : 1543 - 1550
  • [6] Synthesis, enzymatic hydrolysis, and anti-HIV activity of AZT-spacer-curdlan sulfates
    Gao, Y
    Katsuraya, K
    Kaneko, Y
    Mimura, T
    Nakashima, H
    Uryu, T
    [J]. MACROMOLECULES, 1999, 32 (25) : 8319 - 8324
  • [7] Gordon M, 1997, J MED, V28, P108
  • [8] GORDON M, 1994, J MED, V25, P163
  • [9] Hansen JE, 1996, PROTEINS, V25, P1, DOI 10.1002/(SICI)1097-0134(199605)25:1<1::AID-PROT1>3.0.CO
  • [10] 2-N